Authors:
McGaha, T
Saito, S
Phelps, RG
Gordon, R
Noben-Trauth, N
Paul, WE
Bona, C
Citation: T. Mcgaha et al., Lack of skin fibrosis in tight skin (TSK) mice with targeted mutation in the interleukin-4R alpha and transforming growth factor-beta genes, J INVES DER, 116(1), 2001, pp. 136-143
Authors:
Payet-Jamroz, M
Helm, SLT
Wu, JH
Kilmon, M
Fakher, M
Basalp, A
Tew, JG
Szakal, AK
Noben-Trauth, N
Conrad, DH
Citation: M. Payet-jamroz et al., Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells, J IMMUNOL, 166(8), 2001, pp. 4863-4869
Authors:
Terabe, M
Matsui, S
Noben-Trauth, N
Chen, HJ
Watson, C
Donaldson, DD
Carbone, DP
Paul, WE
Berzofsky, JA
Citation: M. Terabe et al., NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway, NAT IMMUNOL, 1(6), 2000, pp. 515-520
Authors:
Radu, DL
Noben-Trauth, N
Hu-Li, J
Paul, WE
Bona, CA
Citation: Dl. Radu et al., A targeted mutation in the IL-4R alpha gene protects mice against autoimmune diabetes, P NAS US, 97(23), 2000, pp. 12700-12704
Citation: N. Noben-trauth et al., Conventional, naive CD4(+) T cells provide an initial source of IL-4 during Th2 differentiation, J IMMUNOL, 165(7), 2000, pp. 3620-3625
Authors:
Jankovic, D
Kullberg, MC
Noben-Trauth, N
Caspar, P
Paul, WE
Sher, A
Citation: D. Jankovic et al., Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4(+) lymphocytes with a Th2 cytokine profile, J IMMUNOL, 164(6), 2000, pp. 3047-3055
Authors:
Potter, MR
Noben-Trauth, N
Weis, JH
Teuscher, G
Weis, JJ
Citation: Mr. Potter et al., Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borreliaburgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes, INFEC IMMUN, 68(10), 2000, pp. 5603-5609
Authors:
Jankovic, D
Kullberg, MC
Noben-Trauth, N
Caspar, P
Ward, JM
Cheever, AW
Paul, WE
Sher, A
Citation: D. Jankovic et al., Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile, J IMMUNOL, 163(1), 1999, pp. 337-342
Authors:
Yamaguchi, M
Sayama, K
Yano, K
Lantz, CS
Noben-Trauth, N
Ra, C
Costa, JJ
Galli, SJ
Citation: M. Yamaguchi et al., IgE enhances Fc epsilon receptor I expression and IgE-dependent release ofhistamine and lipid mediators from human umbilical cord blood-derived mastcells: Synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release, J IMMUNOL, 162(9), 1999, pp. 5455-5465
Citation: N. Noben-trauth et al., IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains, J IMMUNOL, 162(10), 1999, pp. 6132-6140
Authors:
Schuler, T
Qin, ZH
Ibe, S
Noben-Trauth, N
Blankenstein, T
Citation: T. Schuler et al., T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice, J EXP MED, 189(5), 1999, pp. 803-810